Yanqin K. Zhang - Publications

Albuminuria drives hyperlipidemia in patients with Alport syndrome.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 15, 2026

Finerenone Added to Renin-Angiotensin System- and Sodium-Glucose Cotransporter 2 Inhibition in Patients with Alport Syndrome: A Two-Center Case Series.

Journal: Kidney360

Published: April 30, 2026

'Missing' disease-causing variants in Alport syndrome.

Journal: Nature reviews. Nephrology

Published: February 09, 2026

New therapeutic hope for rare podocytopathies.

Journal: Pediatric nephrology (Berlin, Germany)

Published: January 18, 2026

SPARC upregulation mediates podocyte injury in Alport syndrome mice.

Journal: BMC nephrology

Published: January 15, 2026

Urine albumin-to-creatinine ratio as a predictor of kidney function decline in Alport syndrome.

Journal: Clinical kidney journal

Published: November 02, 2025

SGLT2-Inhibition in Patients With Alport Syndrome.

Journal: Kidney international reports

Published: July 23, 2024

Characterization of Ocular Morphology in Col4a3-/- Mice as a Murine Model for Alport Syndrome.

Journal: Translational vision science & technology

Published: July 23, 2024

A retrospective study of kidney disease in Alport syndrome during and after pregnancy.

Journal: Journal of nephrology

Published: June 07, 2024

A Prediction Model of Disease Progression in X-Linked Alport syndrome Based on Clinical Characteristics and Genetic Variants.

Journal: Kidney international reports

Published: May 26, 2024

Abnormal mRNA Splicing Effect of COL4A3 to COL4A5 Unclassified Variants.

Journal: Kidney international reports

Published: February 13, 2023

The Clinical and Genetic Features in Chinese Children With Steroid-Resistant or Early-Onset Nephrotic Syndrome: A Multicenter Cohort Study.

Journal: Frontiers in medicine

Published: February 27, 2022